Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer.

Abstract

PURPOSE Hypofractionated radiotherapy has an intrinsically different normal tissue and tumor radiobiology. The results of a prospective trial of stereotactic body radiotherapy (SBRT) for prostate cancer with long-term patient-reported toxicity and tumor control rates are presented. METHODS AND MATERIALS From 2003 through 2009, 67 patients with clinically… (More)
DOI: 10.1016/j.ijrobp.2010.11.054

1 Figure or Table

Topics

  • Presentations referencing similar topics